BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17926481)

  • 21. [Progress due to genetic research on rheumatoid arthritis: hype or hope?].
    Jacobs JW; Huizinga TW; Bijlsma JW; van der Helm-van Mil AH
    Ned Tijdschr Geneeskd; 2009; 153():A206. PubMed ID: 19785838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis treated with anti-tumour necrosis factor agents.
    Russell AS; Maksymowych WP; de Silva M
    Ann Rheum Dis; 2005 Dec; 64(12):1807. PubMed ID: 16284357
    [No Abstract]   [Full Text] [Related]  

  • 23. [Antibodies against cyclic citrullinated peptide indicate rheumatoid arthritis].
    Ljung L; Uddhammar A; Rantapää-Dahlqvist S
    Lakartidningen; 2009 Aug 5-18; 106(32-33):1964-6. PubMed ID: 19764372
    [No Abstract]   [Full Text] [Related]  

  • 24. Contribution of PTPN22 1858T, TNFRII 196R and HLA-shared epitope alleles with rheumatoid factor and anti-citrullinated protein antibodies to very early rheumatoid arthritis diagnosis.
    Goëb V; Dieudé P; Daveau R; Thomas-L'otellier M; Jouen F; Hau F; Boumier P; Tron F; Gilbert D; Fardellone P; Cornélis F; Le Loët X; Vittecoq O
    Rheumatology (Oxford); 2008 Aug; 47(8):1208-12. PubMed ID: 18535030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnostic and prognostic significance of antibodies against citrullinated peptides].
    Schulze-Koops H; Manger B
    Dtsch Med Wochenschr; 2006 Feb; 131(6):269-71. PubMed ID: 16463231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosing early-onset rheumatoid arthritis: the role of anti-CCP antibodies.
    Vasishta A
    Am Clin Lab; 2002; 21(7):34-6. PubMed ID: 12380030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and significance of antibodies to citrullinated human papilloma virus-47 E2345-362 in rheumatoid arthritis.
    Shi J; Sun X; Zhao Y; Zhao J; Li Z
    J Autoimmun; 2008 Sep; 31(2):131-5. PubMed ID: 18511237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibodies to citrullinated human fibrinogen synthetic peptides in diagnosing rheumatoid arthritis.
    Pérez ML; Gómara MJ; Ercilla G; Sanmartí R; Haro I
    J Med Chem; 2007 Jul; 50(15):3573-84. PubMed ID: 17585853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What can we learn from treatment-induced changes in rheumatoid factor and anti-citrullinated Peptide antibodies?
    Bobbio-Pallavicini F; Caporali R; Bugatti S; Montecucco C
    J Rheumatol; 2008 Oct; 35(10):1903-5. PubMed ID: 18843754
    [No Abstract]   [Full Text] [Related]  

  • 30. IgM-rheumatoid factor, anti-cyclic citrullinated peptide, and anti-citrullinated human fibrinogen antibodies decrease during treatment with the tumor necrosis factor blocker infliximab in patients with rheumatoid arthritis.
    Vis M; Bos WH; Wolbink G; Voskuyl AE; Twisk JW; Van de Stadt R; Hamann D; Dijkmans BA; Lems WF
    J Rheumatol; 2008 Mar; 35(3):425-8. PubMed ID: 18322974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis.
    Xue Y; Zhang J; Chen YM; Guan M; Zheng SG; Zou HJ
    Scand J Rheumatol; 2008; 37(3):183-7. PubMed ID: 18465452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoantibodies to citrullinated proteins: ACPA.
    Vincent C; Nogueira L; Clavel C; Sebbag M; Serre G
    Autoimmunity; 2005 Feb; 38(1):17-24. PubMed ID: 15804701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Anti-citrullinated peptide antibodies: novel markers for rheumatoid polyarthritis].
    Yalaoui S
    Arch Inst Pasteur Tunis; 2006; 83(1-4):13-7. PubMed ID: 19388592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new strategy for the early diagnosis of rheumatoid arthritis: a combined approach.
    Tedesco A; D'Agostino D; Soriente I; Amato P; Piccoli R; Sabatini P
    Autoimmun Rev; 2009 Jan; 8(3):233-7. PubMed ID: 18708166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antibodies against citrullinated proteins--a breakthrough in rheumatologic diagnostics].
    Rönnelid J; Klareskog L; Skogh T; Svensson B
    Lakartidningen; 2004 Dec; 101(50):4092-6. PubMed ID: 15631262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibodies to citrullinated proteins in arthritis: pathology and promise.
    Klareskog L; Widhe M; Hermansson M; Rönnelid J
    Curr Opin Rheumatol; 2008 May; 20(3):300-5. PubMed ID: 18388522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative performance analysis of 4 different anti-citrullinated protein assays in the diagnosis of rheumatoid arthritis.
    Mutlu N; Bicakcigil M; Tasan DA; Kaya A; Yavuz S; Ozden AI
    J Rheumatol; 2009 Mar; 36(3):491-500. PubMed ID: 19228660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-citrullinated peptide antibodies is more than an accurate tool for diagnosis of rheumatoid arthritis.
    Goldman K; Gertel S; Amital H
    Isr Med Assoc J; 2013 Sep; 15(9):516-9. PubMed ID: 24340846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Easy and accurate diagnosis of rheumatoid arthritis using anti-cyclic citrullinated peptide 2 antibody, swollen joint count, and C-reactive protein/rheumatoid factor.
    Yamane T; Hashiramoto A; Tanaka Y; Tsumiyama K; Miura Y; Shiozawa K; Chihara K; Shiozawa S
    J Rheumatol; 2008 Mar; 35(3):414-20. PubMed ID: 18203327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic characteristics of a gelatin based Waaler-Rose assay (Serodia-RA) for the detection of rheumatoid factor.
    Spiritus T; Verschueren P; Westhovens R; Bossuyt X
    Ann Rheum Dis; 2004 Sep; 63(9):1169-71. PubMed ID: 15308531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.